A Long‐Term Extension Study of Bevacizumab in Patients With Solid Tumors

BACKGROUND: Bevacizumab has been studied in numerous clinical trials in multiple types of cancer; however, patients may receive bevacizumab over an extended period of time. This study assessed the long‐term safety and tolerability of bevacizumab among patients with solid tumors. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Oza, Amit M., Dubois, François, Hegg, Roberto, Hernández, Carlos Alberto, Finocchiaro, Gaetano, Ghiringhelli, François, Zamagni, Claudio, Nick, Sonja, Irahara, Natsumi, Perretti, Thomas, Colombo, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
New Drug Development and Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649003/
https://www.ncbi.nlm.nih.gov/pubmed/34498344
http://dx.doi.org/10.1002/onco.13971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649003/
https://www.ncbi.nlm.nih.gov/pubmed/34498344
http://dx.doi.org/10.1002/onco.13971

Ejemplares similares